Skip to main content
. 2017 Jun 6;5:2050312117712887. doi: 10.1177/2050312117712887

Table 3.

Distribution of patients who had >50% seizure reduction with statistical significance.

>50% seizure reduction
1 month 3 months 6 months 9 months 12 months
Gender
 Male 14 (48%) 16 (55%) 10 (34%) 7 (24%) 9 (31%)
 Female 24 (71%) 21 (62%) 18 (53%) 13 (38%) 14 (41%)
 Chi-square/p-value 0.091 0.298 0.121 0.304 0.589
Seizure type
 Generalized, n = 59 34 (58%) 33 (56%) 25 (42%) 16 27%) 20 (34%)
 Focal, n = 4 4 (100%) 4 (100%) 3 (75%) 3 (75%) 3 (75%)
 Chi-square/p-value 0.132 0.136 0.761 0.299 0.443
Age at seizure onset
 ⩽1 year, n = 42 28 (67%) 22 (52%) 18 (43%) 12 (29%) 13 (31%)
 >1 year, n = 21 10 (48%) 15 (71%) 10 (48%) 8 (38%) 10 (48%)
 Chi-square/p-value 0.284 0.144 0.865 0.124 0.09
Age at diet onset
 ⩽8 year, n = 50 30 (60%) 32 (64%) 21 (42%) 16 (32%) 4 (31%)
 >8 year, n = 13 8 (62%) 5 (38%) 7 (54%) 4 (31%) 2 (15%)
 Chi-square/p-value 0.73 0.467 0.488 0.737 0.147
Method of diet induction
 Non-fasting, n = 50 29 (58%) 29 (58%) 22 (44%) 14 (28%) 16 (32%)
 Fasting, n = 13 9 (69%) 8 (62%) 6 (46%) 6 (46%) 7 (54%)
 Chi-square/p-value 0.206 0.960 0.105 0.200 0.826
Cognitive delays
 Severe, n = 43 25 (58%) 23 (53%) 18 (42%) 10 (23%) 11 (26%)
 Mild/moderate delays/normal, n = 20 13 (65%) 14 (70%) 10 (50%) 10 (50%) 12 (60%)
 Chi-square/p-value 0.47 0.388 0.523 0.326 0.315
Seizure frequency
 0–10 seizure/day, n = 42 24 (57%) 21 (50%) 15 (36%) 13 (31%) 16 (38%)
 >10 seizure/day, n = 21 14 (67%) 16 (76%) 13 (62%) 7 (33%) 7 (33%)
 Chi-square/p-value 0.602 0.100 0.054 0.301 0.199